15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)

Overview of attention for article published in Journal of Clinical Oncology, July 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 11 news outlets
twitter: 8 X users

facebook: 1 Facebook page
bluesky: 1 Bluesky user

Readers on

mendeley: 31 Mendeley

So far, Altmetric has seen 13 news stories from 11 outlets.

Combination of Castle Biosciences’ DecisionDx-UM and PRAME show predicting outcomes in patients with uveal melanoma: Study

Pharmabiz.com, 19 Dec 2025

Castle Biosciences Inc, a company improving health through innovative tests that guide patient care, announced new data from…

DecisionDx-UM and PRAME Improve Metastatic Risk Prediction in Uveal Melanoma

Dermatology Times, 17 Dec 2025

Uveal melanoma (UM) remains the most common primary intraocular malignancy in adults and one of the most challenging ocular…

Landmark Study Shows Combination of Castle Biosciences' DecisionDx(TM)-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma

Stockwatch, 17 Dec 2025

FRIENDSWOOD, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through…

Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma

Yahoo! Finance USA, 17 Dec 2025

FRIENDSWOOD, Texas, Dec. 17, 2025 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 9 additional news stories.